secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-08-20T12:30:43+00:00
Accession:  0001493152-26-039375
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity Technologies announces 1-for-15 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split effective at open of trading on Aug 24, 2026; every 15 shares become 1 share of BIAF.
- Post-split shares outstanding ~592,373; new CUSIP 09076W406.
- Split aims to meet Nasdaq minimum bid price requirement; no change to authorized shares or par value.
- Proportionate adjustments made to outstanding stock options, RSUs, and warrants; fractional shareholders get cash.
- Stockholders of record receive transfer agent notice; trading symbol remains BIAF.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226039375/0001493152-26-039375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226039375/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-039375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer